Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755 AM2)
This study is currently recruiting participants.
Verified May 2013 by Merck
Study NCT01544920
Information provided by Merck
First Received on February 28, 2012.
Last Updated on May 10, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
